Company intelligence / Profile preview

MedClaris

Ownership: Private
Development stage: Commercial

Overview

MedClaris is a South Korean company specializing in business development services for international life science and healthcare companies seeking entry into the South Korean market. The company offers regulatory support—including assistance with Korean FDA and EMA documentation—technology evaluation for investors, and consulting on market access and reimbursement. It does not develop its own therapeutic products or maintain an internal clinical pipeline[1][2].

Industry: Consulting

Partnerships

Collaborates with Turku Science Park Ltd and CB Health Access project as part of initiatives to help European health tech companies enter the South Korean marketProvides technology evaluation to Asian fund managers/investors

Beyond the preview

Go deeper on MedClaris.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedClaris.

Explore the full profile